Simon Francis Thomsen

Simon Francis Thomsen

Professor

Member of:


    Publication year:
    All
    181 - 190 out of 307Page size: 10
    1. 2019
    2. Published

      Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

      gvs142, gvs142 & Thomsen, Simon Francis, 2019, In: Journal of Dermatological Treatment. 30, 4, p. 387-388

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations

      Dombernowsky, T., Hædersdal, Merete, Lassen, Ulrik Niels & Thomsen, Simon Francis, 2019, In: Trials. 20, 12 p., 708.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march

      Holm, J. G., Agner, Tove, Clausen, M. & Thomsen, Simon Francis, 2019, In: Archives of Dermatological Research. 311, 3, p. 173-182

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis

      Lund, T., Sand, C., Gniadecki, R. & Thomsen, Simon Francis, 2019, In: Dermatologic Therapy. 32, 3, 2 p., e12846.

      Research output: Contribution to journal › Letter › Research › peer-review

    6. Published

      Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection

      Saunte, Ditte Marie, Hare, R. K., Jorgensen, K. M., Jorgensen, R., Deleuran, M., Zachariae, Claus, Thomsen, Simon Francis, Bjornskov-Halkier, L., Kofoed, K. & Arendrup, Maiken Cavling, 2019, In: Antimicrobial Agents and Chemotherapy. 63, 10, 9 p., e01126-19.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy

      Humbert, M., Bousquet, J., Bachert, C., Palomares, O., Pfister, P., Kottakis, I., Jaumont, X., Thomsen, Simon Francis & Papadopoulos, N. G., 2019, In: The Journal of Allergy and Clinical Immunology: In Practice. 7, 5, p. 1418-1429

      Research output: Contribution to journal › Review › Research › peer-review

    8. Published

      Isotretinoin and hidradenitis suppurativa

      Jorgensen, A. -. R., Thomsen, Simon Francis & Ring, H. C., 2019, In: Clinical and Experimental Dermatology. 44, 4, p. E155-E156

      Research output: Contribution to journal › Letter › Research › peer-review

    9. Published

      Omalizumab for atopic dermatitis: evidence for and against its use

      Holm, J. G. & Thomsen, Simon Francis, 2019, In: Giornale Italiano di Dermatologia e Venereologia. 154, 4, p. 480-487

      Research output: Contribution to journal › Review › Research › peer-review

    10. Published

      Patient expectations and determinants of patient satisfaction in a dermatology outpatient clinic

      Sondergaard, M. B., Ghazanfar, M. N. & Thomsen, Simon Francis, 2019, In: Journal of the European Academy of Dermatology and Venereology. Supplement. 33, 1, p. E32-E33

      Research output: Contribution to journal › Letter › Research › peer-review

    11. Published

      Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis

      Ghazanfar, M. N., Karlsmark, Tonny, Danielsen, P. L. & Thomsen, Simon Francis, 2019, In: Clinical Case Reports. 7, 7, p. 1350-1351

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1...15 16 17 18 19 20 21 22 ...31 Next

    ID: 32452372